MEI Pharma, Inc. (MEIP)
NASDAQ: MEIP · IEX Real-Time Price · USD
2.800
-0.050 (-1.75%)
Jul 2, 2024, 4:30 PM EDT - Market closed
MEI Pharma Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for MEI Pharma stock has a target of 7.00, which predicts an increase of 150.00% from the current stock price of 2.80.
Analyst Consensus: Hold
* Price targets were last updated on Apr 12, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for MEI Pharma is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 1 | 1 | 1 | 1 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 3 | 1 | 1 | 1 | 1 | 1 |
| Sell | 1 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 2 | 2 | 2 | 2 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel | Stifel | Hold Maintains $7 | Hold | Maintains | $7 | +150.00% | Apr 12, 2024 |
| Stifel | Stifel | Hold Maintains $8 → $7 | Hold | Maintains | $8 → $7 | +150.00% | Feb 14, 2024 |
| Stifel | Stifel | Hold Maintains $10 → $9 | Hold | Maintains | $10 → $9 | +221.43% | Sep 27, 2023 |
| Brookline Capital | Brookline Capital | Strong Buy Maintains $80 | Strong Buy | Maintains | $80 | +2,757.14% | May 23, 2023 |
| Stifel | Stifel | Hold Maintains $0.5 → $10 | Hold | Maintains | $0.5 → $10 | +257.14% | May 12, 2023 |
Financial Forecast
Revenue This Year
66.60M
from 48.82M
Increased by 36.44%
Revenue Next Year
6.38M
from 66.60M
Decreased by -90.43%
EPS This Year
3.69
from -4.78
EPS Next Year
-5.80
from 3.69
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 68.6M | 13.1M | 26.3M | 26.3M | 26.3M |
| Avg | 66.6M | 6.4M | 25.5M | 25.5M | 25.5M |
| Low | 64.0M | n/a | 24.5M | 24.5M | 24.5M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 40.4% | -80.3% | 311.8% | 2.9% | 2.9% |
| Avg | 36.4% | -90.4% | 300.0% | - | - |
| Low | 31.1% | - | 284.3% | -3.9% | -3.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 4.22 | -5.35 | -3.90 | -1.25 | -1.18 |
| Avg | 3.69 | -5.80 | -3.78 | -1.21 | -1.14 |
| Low | 3.16 | -6.15 | -3.64 | -1.17 | -1.10 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.